These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1353880

  • 1. c-erbB-2 expression in primary gastric carcinomas and their metastases.
    David L, Seruca R, Nesland JM, Soares P, Sansonetty F, Holm R, Børresen AL, Sobrinho-Simões M.
    Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880
    [Abstract] [Full Text] [Related]

  • 2. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
    Takamura H, Yonemura Y, Hirono Y, Ninomiya I, Sahara H, Tsugawa K, Matsumoto H, Sugiyama K, Fujimura T, Nishimura G.
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
    [Abstract] [Full Text] [Related]

  • 3. c-erbB-2 amplification in node-negative human breast cancer.
    Ro JS, el-Naggar A, Ro JY, Blick M, Frye D, Fraschini G, Fritsche H, Hortobagyi G.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6941-4. PubMed ID: 2573424
    [Abstract] [Full Text] [Related]

  • 4. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
    Coleman RL, Schink JC, Miller DS, Bauer KD, August CZ, Rademaker AW, Lurain JR.
    Gynecol Oncol; 1993 Jul 15; 50(1):20-4. PubMed ID: 8349159
    [Abstract] [Full Text] [Related]

  • 5. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC, Dietrich KD, Danyluk J, Paterson AH, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA.
    Cancer Res; 1991 Jan 15; 51(2):556-67. PubMed ID: 1670762
    [Abstract] [Full Text] [Related]

  • 6. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
    Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR.
    Cancer Res; 1990 Oct 15; 50(20):6701-7. PubMed ID: 2208136
    [Abstract] [Full Text] [Related]

  • 7. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
    Shiga K, Shiga C, Sasano H, Miyazaki S, Yamamoto T, Yamamoto M, Hayashi N, Nishihira T, Mori S.
    Anticancer Res; 1993 Oct 15; 13(5A):1293-301. PubMed ID: 7902061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM.
    Hepatogastroenterology; 1997 Oct 15; 44(14):604-9. PubMed ID: 9164544
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.
    Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T.
    Cancer Res; 1991 Feb 01; 51(3):1034-8. PubMed ID: 1670998
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome.
    Krüger S, Weitsch G, Büttner H, Matthiensen A, Böhmer T, Marquardt T, Sayk F, Feller AC, Böhle A.
    Int J Oncol; 2002 Nov 01; 21(5):981-7. PubMed ID: 12370744
    [Abstract] [Full Text] [Related]

  • 13. [DNA ploidy pattern and p53 overexpression in gastric cancer].
    Tomisaki S, Tatsuo O, Hisao O, Sakaguchi Y, Kusumoto T, Ohno S, Ichiyoshi Y, Maehara Y, Sugimachi K.
    Gan To Kagaku Ryoho; 1995 Jun 01; 22 Suppl 2():115-7. PubMed ID: 7611772
    [Abstract] [Full Text] [Related]

  • 14. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
    Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH.
    Cancer Res; 1989 Dec 01; 49(23):6605-9. PubMed ID: 2573419
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y, Booser DJ, Sneige N.
    Cancer; 2005 May 01; 103(9):1763-9. PubMed ID: 15786420
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF, Xu HM, Chen JQ.
    Chin Med J (Engl); 2004 Oct 01; 117(10):1530-5. PubMed ID: 15498378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.